3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
185
Neoplasms
11
Prostate Adenocarcinoma
3
Neoplasm Metastasis
3
Adenocarcinoma
2
Urogenital Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Prostatic Diseases
1
Primary Dysautonomias
1
PSA Level Greater Than Two
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms, Glandular and Epithelial
1
Lymphatic Metastasis
1
Lower Urinary Tract Symptoms
1
Kidney Diseases
1
Hypertension
1
Hormone Sensitive Prostate Cancer
1
Genital Neoplasms, Male
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Carcinoma
1
Advanced Prostate Cancer
1
Advanced Prostate Adenocarcinoma
1
Interventions
mirabegron
1
bicalutamide
1
Tamoxifen
1
Sugars
1
Sodium Chloride
1
Radiotherapy
1
Pentosan Sulfuric Polyester
1
Leuprolide
1
Dutasteride
1
Doxazosin
1
Diclofenac
1
Cystoscopy
1
Celecoxib
1
Catheters, Indwelling
1
Capsules
1
Botulinum Toxins, Type A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lower Urinary Tract Symptoms
×
Leuprolide
×
Genitourinary
×
Clear all
NCT01078545
2012-01-16
LEMON
Abbott
Completed
729 enrolled
14 charts